A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults
Clinical trial NCT06431607 · COMPLETED
Trial details
- NCT number
- NCT06431607
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-23
- Primary completion
- 2024-12-27
- Enrollment
- 845
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.